INTRODUCTION
Right ventricular infarction (RVI) was first recognized in a sub-group of patients with inferior wall myocardial infarction (MI) in whom right ventricle (RV) failure and elevated right ventricular filling pressure despite of relatively normal left ventricular (LV) filling pressure was observed. Post-mortem studies revealed that there is RV involvement in 19% to 51% of patients with acute inferior wall MI. RVI contributes significantly to haemodynamic instability, atrioventricular (AV) block, bradycardia requiring pacing support and in-hospital mortality and morbidity. 1 The diagnosis of RVI can be made from physical examination, echocardiography, first pass/ equilibrium radionuclide ventriculography, technetium pyrophosphate myocardial scintigram, haemodynamic measurements and angiography. But, right precordial electrocardio-Patients with associated anterior and lateral wall MI, proved by ST elevation in anterior and lateral leads in ECG and wall motion abnormalities by echocardiography, a history of previous MI; ECG evidence of left bundle branch block (LBBB); cor-pulmonale; suspected pulmonary embolism; associated pericardial disease; and patients not consenting to participate were excluded from the study. RVMI was diagnosed based on the criteria listed in Table 1 .
In all patients, a detailed history was taken and careful physical examination was done with special reference to haemodynamic parameters like jugular venous pulse (JVP), Kussmaul's sign, hypotension, presence of third and fourth heart sounds and cardiac murmur. They were also evaluated for coronary risk factors like smoking, hypertension, diabetes mellitus, obesity, alcohol and hypercholesterolaemia.
In all of them 12-lead ECG, cardiac enzyme assay and echocardiography were carried out. The 12-lead ECG recordings were made at 25 mm/sec speed and 1 mV=10mm setting. Right precordial leads (RPL) were applied on the right side of chest on the areas to which the leads corresponded on the left. Lead II ECG monitoring was done during the stay in ICU for identification of arrhythmias and conduction blocks. Echocardiography was done in all patients and compared with ECG findings. Coronary angiography was done in selected patients who could afford the procedure.
Other laboratory investigations included random plasma glucose, fasting lipid profile, blood urea nitrogen, along with serum lactate dehydrogenase (LDH) and serum aspartate aminotransferase (AST), CKMB (immunoinhibition method; Erba creatine kinase-MB kit, Transasia biomedicals Ltd.); TROP I (lateral flow immunochromatic test, Instant view trop I whole blood/serum kit, Alfa scientific design). All patients with inferior wall MI were divided into RVI and non RVI group based on right precordial ECG findings.
Statistical analysis
Descriptive statistical analysis was carried out and results on continuous measurements have been presented on mean ± standard deviation (SD). Results on categorical measurements have been presented in number (%). Significance was assessed at 5 % level of significance. Chi-square, Fisher's exact tests were used to compare categorical variables. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were computed for 12-lead ECG and RPL, considering ST elevation greater than 1 mm in any of the RPL as 'gold standard'.
RESULTS
Of the 50 cases with inferior wall MI, 16 (32%) cases had evidence of RVI. Their mean age was 54.5 ± 11.9 years; there were 42 (84%) males. Most of the patients (30%) were in the age group of 51 -60 years. Smoking was the major risk factor in 41 (82%) patients followed by hypertension in 22 (44%). They presented with chest pain (100%), sweating (86%) and syncope (2%) in RVI group. Comparison of physical examination findings in patients with and without RVI is shown in Table 2. ST elevation of greater then 1 mm in one of the RPL indicating RVI was evident in 16 cases, of which 6 cases showed ST elevation in all 4 leads, namely, V 3 R -V 6 R ( Figure 1 ). ST-elevation was most commonly seen in lead V 4 R and V 5 R (87.5%) ( Figure 2 ). In addition to RPL, ST elevation of 1 mm or more in lead III, ratio III/II greater than 1 was found in the 12-lead ECG in 14 patients (58.3%) in RVI group and 10 patients (41.7%) in non-RVI group. Echocardiography criteria 3 of RVI, suggestive of RV dilatation was observed in both the groups. Thirteen patients showed right ventricular end-diastolic dimension, (RVEDD) greater than 25 mm indicating RV dilation of which 10 (92.3%) had evidence of RV infarction. Also, 9 of the 10 patients with ratio of RVEDD to left ventricular end-diastolic dimension, (RVEDD/LVEDD) greater than 0.7 had evidence of RVI. Table 3 shows the sensitivity, specificity, PPV, NPV and accuracy of 12-lead ECG criteria and RPL in diagnosing RVI.
Comparison of the sensitivity of right precordial leads (V 3 R-V 6 R) in diagnosing RVI in the present study and other published studies is shown in Table 4 .
Complications like sinus bradycardia, atrioventricular block, asystole and multiple ventricular premature complexes (VPCs) in patients with and without RVI is shown in Table 5 .
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DISCUSSION
In the present study, RVI was evident in 32% of cases with inferior wall MI. A similar prevalence of RVI of 30% 10 and 37% 11 has been reported in other studies in patients with inferior wall MI. RVI is less common since RV is less susceptible to ischaemia as oxygen demand is significantly lesser because of its smaller muscle mass 12, 13 and coronary perfusion in right ventricle occurs in both systole and diastole. 14 Most of the cases (46.7%) of RVI occurred in the age group of 51 -60 years in the RVI group compared to non-RVI that was commonly (84.6%) seen in the age group of 41-50 years. In the present study 84% were males. Similar male preponderance (86%) was reported in another study. 15 Among the 42 male patients in our study 13 (31 %) had RVI while only 3 of the 8 women (37.5%) had evidence of RVI; however, this difference did not attain statistical significance. In another study, 16 it was observed that prevalence of RVI increased as age advanced and prognostic effect of RVI was independent of gender. All the patients in the study presented with chest pain. Prevalence of RVI was associated more with vomiting (41.6%), breathlessness (40%) and syncope (100%). A patient with RVI who also had complete heart block presented with syncope. Patients with RVI and complete heart block have been observed to present with episodes of syncope classically described as Stokes-Adams attack. 17 In the present study among RPL, V 3 R had sensitivity of 37% and lead V 4 R and V 5 R showed sensitivity of 87.5% for identifying ST elevation greater than 1 mm suggestive of RVI (Table 3) . In most studies (Table 4) 1,4-9 lead V 4 R was found to be the most sensitive among all RPL in detecting RVI (Table 4 ). An ST segment which is higher in lead V 4 R than in leads V I to V 3 offers the highest specificity and efficiency in diagnosis. 2 Comparing the reliability of 12-lead ECG criteria with that of RPL in diagnosing RVI, we found that 12-lead ECG finding of ST elevation greater than 1 mm in lead III, ST elevation in lead III/II greater than 1, had poor sensitivity (75%), specificity (88.2%), PPV(75%), NPV (88.2%) and accuracy (84%). In a study 19 evaluating the reliability of 12-lead ECG criteria in the diagnosis of RVI, it was found that the right sided chest leads had a higher specificity and PPV than inferior leads, but poor sensitivity, NPV, and accuracy. However, the differences were not statistically significant. In right chest leads recognition of infarction signals is easy because only the presence of ST elevation of 1 mm or more is re-quired to diagnose RVI but in inferior leads a difference between ST elevation in two leads must be interpreted. Thus right precordial leads appear to be a better indicator of RVI than 12-lead ECG.
In the present study, among patients in whom RVI was confirmed by echocardiography criteria, 3 RPL evidence of RVI was evident in more than 90 percent of cases. In another study 20 of 42 inferior wall MI patients, 16 had an echocardiography evidence suggestive of RV dilatation; this included 12 with V 4 R evidence of RVI.
Cardiogenic shock was the cause of death in 2 cases in our study of which 1 had evidence of RV involvement. It has been observed that inferior wall MI patients who also have RV myocardial involvement are at risk of death, cardiogenic shock and arrhythmia. 21 Among the 8 patients with inferior wall MI treated with volume replacement, 6 had evidence of RVI in the present study. Patients with RVI who are haemodynamically unstable should be managed with volume loading to maintain adequate RV preload as preload determines RV output. Any interventions that reduce the preload, like diuretics, nitrates and vasodilators should be avoided even in the absence of hypotension as this will lead to worsening of symptoms. This treatment strategy would differ from therapy for pump failure caused by acute left ventricular infarction due to need for maintaining the RV preload in acute RV infarction. 22 Our observations suggest that RVI occurs in more than one-third of patients with acute inferior wall MI. A spectrum of disease from asymptomatic mild right ventricular dysfunction to cardiogenic shock has been recognized. All the patients with inferior wall MI should have right sided precordial leads recorded as early as possible for evidence of RVI, of which V 4 R and V 5 R have highest sensitivity. The diagnosis can be further confirmed by echocardiography for RV dilatation thus helping in preventing the complications and mortality associated with it. 
